Newly-launched U.S. drugs head toward record-high prices in 2022 - Reuters

Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill for prescription drugs in the United States.

Aug 15 (Reuters) - Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billio… [+5464 chars]

full article...